| Product NDC: | 43689-0009 |
| Proprietary Name: | Tinnitus Relief |
| Non Proprietary Name: | Calcarea Carbonica, Chininum Sulphuricum, Kali Carbonicum, Lycopodium Clavatum, Salicylicum Acidum |
| Active Ingredient(s): | 6; 6; 6; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 & nbsp; Calcarea Carbonica, Chininum Sulphuricum, Kali Carbonicum, Lycopodium Clavatum, Salicylicum Acidum |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43689-0009 |
| Labeler Name: | The Magni Company |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Start Marketing Date: | 20120816 |
| Package NDC: | 43689-0009-1 |
| Package Description: | 125 TABLET in 1 BOTTLE (43689-0009-1) |
| NDC Code | 43689-0009-1 |
| Proprietary Name | Tinnitus Relief |
| Package Description | 125 TABLET in 1 BOTTLE (43689-0009-1) |
| Product NDC | 43689-0009 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Calcarea Carbonica, Chininum Sulphuricum, Kali Carbonicum, Lycopodium Clavatum, Salicylicum Acidum |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120816 |
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
| Labeler Name | The Magni Company |
| Substance Name | LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM CARBONATE; QUININE SULFATE; SALICYLIC ACID |
| Strength Number | 6; 6; 6; 6; 6 |
| Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
| Pharmaceutical Classes |